Trial
NCT02873702
Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive Esophagitis
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Takeda
Collaborators
—
Condition
Erosive Esophagitis
Intervention
Dexlansoprazole
Why stopped
Compound is not expected to change the current treatment practice or fill significant clinical need for patients in China over currently available EE agents.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-22